183
Participants
Start Date
December 8, 2022
Primary Completion Date
December 30, 2026
Study Completion Date
December 30, 2026
Teriparatide
Teriparatide, an injectable synthetic parathyroid hormone, will be tested to evaluate its efficacy for decreasing the convalescence after a diaphyseal tibial stress fracture, a specific bone stress injury.
Placebos
Placebo will be a sugar solution of the manufacturer's design.
Fort Jackson, Columbia
United States Department of Defense
FED
Eisenhower Army Medical Center
FED
Moncrief Army Health Clinic
UNKNOWN
University of South Carolina
OTHER